Aditxt, Inc. Repayments of Assumed Debt
Aditxt, Inc. (ADTX) had Repayments of Assumed Debt of $5.36 million as of 2024-01-24, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfAssumedDebt · last filed 2026-05-20
- 2024-01-24: Repayments of Assumed Debt $5.36M.
- 2023-11-07: Repayments of Assumed Debt $3.13M; Repayments of Assumed Debt 0 month $3.13M.
- 2023-10-05: Repayments of Assumed Debt 0 month $4.23M.
| Period end | Repayments of Assumed Debt | Repayments of Assumed Debt 0 month |
|---|---|---|
| 2024-01-24 | $5.36M 10-Q · filed 2026-05-20 | |
| 2023-11-07 | $3.13M 10-Q · filed 2025-11-18 | $3.13M 10-K · filed 2024-04-16 |
| 2023-10-05 | $4.23M 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |